Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subanesthetic esketamine for emergence from sevoflurane anesthesia in thoracoscopic pulmonary surgery
ChiCTR2600133821Phase 4Not yet recruiting
- Sponsor
- Taizhou People's Hospital
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine in Anesthesia-related recovery impairment (ARRI) (2 arms), sponsored by Taizhou People's Hospital. Primary endpoint: Awakening time. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Anesthesia-related recovery impairment (ARRI)
Beyond the preview
Go deeper on ChiCTR2600133821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133821.